HIV Clinical Trials

(ISSN: 1528-4336)

Subscribe Submit

Table of Contents

2016 - 17 (1)

  • Clinical Outcomes of Virologically-Suppressed Patients with Pre-existing HIV-1 Drug Resistance Mutations Switching to Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate in the SPIRIT Study. 
  • Long-Term Efficacy, Tolerability, and Renal Safety of Atazanavir/Ritonavir-based Antiretroviral Therapy in a Cohort of Treatment-Na��ve Patients with HIV-1 Infection: the REMAIN Study. 
  • Dual Raltegravir-Darunavir/Ritonavir Combination in Virologically Suppressed HIV-1-Infected Patients on Antiretroviral Therapy Including a Ritonavir-Boosted Protease Inhibitor Plus Two Nucleoside/Nucleotide Reverse Transcriptase Inhibitors. 
 
 
Member of Medscape Publishers’ Circle®

Mission Statement: HIV Clinical Trials is devoted exclusively to keeping you in touch with the latest developments and techniques in HIV/AIDS therapeutics.

Member of Medscape Publishers’ Circle®
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.